StockClub

ADAPY

ADAPYAdaptimmune Therapeutics plc$ --
Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc

ADAPY

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 06/30/2025FY2025 Q2
Revenue
14M USD
YoY -89.3%
Operating Income
-30M USD
YoY -144.1%
Net Income
-30M USD
YoY -143.6%
EPS
-0.12$
YoY -144.4%

Revenue

$21M
FY2023 Q3$60M
$60M
Q3
FY2023 Q4$60.3M
$60.3M
Q4
FY2024 Q1$5.7M
$5.7M
Q1
FY2024 Q2$133.9M
$133.9M
Q2
FY2024 Q3$174.8M
$174.8M
Q3
FY2024 Q4$178M
$178M
Q4
FY2025 Q1$7.3M
$7.3M
Q1
FY2025 Q2$21M
$21M
Q2
Actual
$-112.9M (-84.3%)

Net Income

$-77.9M
FY2023 Q3$-66M
$-66M
Q3
FY2023 Q4$-114.3M
$-114.3M
Q4
FY2024 Q1$-48.5M
$-48.5M
Q1
FY2024 Q2$21M
$21M
Q2
FY2024 Q3$3.4M
$3.4M
Q3
FY2024 Q4$-70.8M
$-70.8M
Q4
FY2025 Q1$-47.6M
$-47.6M
Q1
FY2025 Q2$-77.9M
$-77.9M
Q2
Actual
$-98.9M (-470.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$1.1M
FY2019
$1.1M
FY2020
Actual:$4M
FY2020
$4M
FY2021
Actual:$6.1M
FY2021
$6.1M
FY2022
Actual:$27.1M
FY2022
$27.1M
FY2023
Actual:$60.3M
FY2023
$60.3M
FY2024MISS
Actual:$178M
Est:$182.7M
FY2024MISS
$178M

Analyst Estimates